Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|April 26, 2007
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 casesErminia Manfrin, Andrea Remo, Francesca Falsirollo, et al.
Advances in Anatomic Pathology|January 2, 2007
Perivascular epithelioid cell tumor (PEComa) in the genitourinary tractGuido Martignoni, Maurizio Pea, Daniela Reghellin, et al.
Virchows Archiv : an International Journal of Pathology|December 15, 2007
PEComas: the past, the present and the futureGuido Martignoni, Maurizio Pea, Daniela Reghellin, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2024
[A case of right heart failure: when it is not pulmonary embolism]Enrico Tadiello, Emma Zimelli, Giulia Urbani, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 2, 2005
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosisAlberto Zamò, Venerino Poletti, Daniela Reghellin, et al.
Archives of Pathology & Laboratory Medicine|January 16, 2010
Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumorsGuido Martignoni, Maurizio Pea, Daniela Reghellin, et al.
Cancer|October 7, 2009
Cancer size, histotype, and cellular grade may limit the success of fine-needle aspiration cytology for screen-detected breast carcinomaErminia Manfrin, Francesca Falsirollo, Andrea Remo, et al.
American Journal of Clinical Pathology|May 16, 2008
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapyMatteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Cancer|January 1, 2009
Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004)Erminia Manfrin, Renata Mariotto, Andrea Remo, et al.
American Journal of Clinical Pathology|April 17, 2009
Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteriaMatteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Pageof 2